MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

Karyopharm Therapeutics Inc

Fechado

SetorSaúde

5.51 -6.93

Visão Geral

Variação de preço das ações

24h

Atual

Mín

5.41

Máximo

5.67

Indicadores-chave

By Trading Economics

Rendimento

1.3M

-31M

Vendas

-8.2M

31M

EPS

-0.24

Margem de lucro

-100.779

Funcionários

279

EBITDA

972K

-20M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+854.98% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

46M

Abertura anterior

12.44

Fecho anterior

5.51

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Karyopharm Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de abr. de 2025, 23:55 UTC

Conversa de Mercado

Oil Edges Higher Amid Hopes for Easing U.S.-China Trade Tensions -- Market Talk

27 de abr. de 2025, 23:47 UTC

Conversa de Mercado

Gold Falls Amid Dollar Strength, Signs of Easing U.S.-China Trade Tensions -- Market Talk

27 de abr. de 2025, 23:42 UTC

Conversa de Mercado

Nikkei May Rise as Fears About U.S.-China Tensions Ebb -- Market Talk

27 de abr. de 2025, 23:12 UTC

Ganhos

Sinopharm Group 1Q Rev CNY141.66B Vs. CNY147.27B >1099.HK

27 de abr. de 2025, 23:12 UTC

Ganhos

Sinopharm Group 1Q Net CNY1.46B Vs. Net CNY1.42B >1099.HK

27 de abr. de 2025, 20:41 UTC

Ganhos

Pharmaron Beijing 1Q Net CNY305.58M Vs. Net CNY230.56M >300759.SZ

27 de abr. de 2025, 20:41 UTC

Ganhos

Pharmaron Beijing: Higher Contributions From Laboratory Services Among Factors Supporting Results> 300759.SZ

27 de abr. de 2025, 20:41 UTC

Ganhos

Pharmaron Beijing 1Q Rev CNY3.10B Vs. CNY2.67B >300759.SZ

27 de abr. de 2025, 18:41 UTC

Principais Notícias

Bessent Doesn't Know If Trump and Xi Have Talked on Trade -- Barrons.com

27 de abr. de 2025, 11:00 UTC

Principais Notícias

Wall Street's New Tariff Safe Haven: High-Tax Biotech Stocks -- Heard on the Street -- WSJ

27 de abr. de 2025, 05:41 UTC

Ganhos

China Everbright Bank 1Q Net CNY12.46B Vs. Net CNY12.43B >601818.SH

27 de abr. de 2025, 05:41 UTC

Ganhos

China Everbright Bank: Lower Net Interest Income Weighed on Operating Income>601818.SH

27 de abr. de 2025, 05:41 UTC

Ganhos

China Everbright Bank 1Q Operating Income CNY33.10B Vs. CNY34.49B>601818.SH

27 de abr. de 2025, 05:41 UTC

Ganhos

China Everbright Bank 1Q Impairment Loss on Credit Assets Was CNY8.49B; Down 15.6% on Year>601818.SH

27 de abr. de 2025, 05:41 UTC

Ganhos

China Everbright Bank 1Q Operating Expenses Was CNY9.15B; Down 3.2%>601818.SH

27 de abr. de 2025, 05:41 UTC

Ganhos

China Everbright Bank 1Q Net Interst Income Was CNY22.54B; Down 6.8% on Year>601818.SH

27 de abr. de 2025, 05:34 UTC

Ganhos

Chongqing Rural Commercial Bank: 1Q Results Supported by Higher Net Interest Income>3618.HK

27 de abr. de 2025, 05:34 UTC

Ganhos

Chongqing Rural Commercial Bank 1Q Operating Income CNY7.22B Vs. CNY7.13B>3618.HK

27 de abr. de 2025, 05:34 UTC

Ganhos

Chongqing Rural Commercial Bank 1Q Net CNY3.75B Vs. Net CNY3.52B >3618.HK

27 de abr. de 2025, 05:29 UTC

Ganhos

China Shenhua Energy: Results Weighed by Fall in Selling Prices of Coal >1088.HK

27 de abr. de 2025, 05:29 UTC

Ganhos

China Shenhua Energy 1Q Net CNY13.37B Vs. Net CNY17.76B >1088.HK

27 de abr. de 2025, 05:29 UTC

Ganhos

China Shenhua Energy 1Q Rev CNY69.59B Vs. CNY87.65B >1088.HK

27 de abr. de 2025, 05:29 UTC

Ganhos

China Shenhua Energy: Lower Revenue From Electricity Sales Also Hurt Results >1088.HK

27 de abr. de 2025, 05:21 UTC

Ganhos

CMOC Group 1Q Net CNY3.95B Vs. Net CNY2.07B >3993.HK

27 de abr. de 2025, 05:21 UTC

Ganhos

CMOC Group: Cost Cuts Also Among Factors that Boosted 1Q Net >3993.HK

27 de abr. de 2025, 05:21 UTC

Ganhos

CMOC Group 1Q Rev CNY46.01B Vs. CNY46.12B >3993.HK

27 de abr. de 2025, 05:21 UTC

Ganhos

CMOC Group: Increase in Prices of Copper, Cobalt Supported Results>3993.HK

27 de abr. de 2025, 03:00 UTC

Principais Notícias

Chinese Manufacturers Are Scouring the World for New Buyers -- WSJ

27 de abr. de 2025, 00:30 UTC

Principais Notícias

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ

27 de abr. de 2025, 00:30 UTC

Principais Notícias

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ -2-

Comparação entre Pares

Variação de preço

Karyopharm Therapeutics Inc Previsão

Preço-alvo

By TipRanks

854.98% parte superior

Previsão para 12 meses

Média 53.67 USD  854.98%

Máximo 105 USD

Mínimo 15 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Karyopharm Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

5

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

5.9501 / 7.66Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

No Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$